Home » Topics » BioWorld Science

BioWorld Science
RSS

AgeX Therapeutics describes new exosomes for wound healing

Aug. 17, 2021

Clinical trial finds PRAX-114 improves symptoms of perimenopausal depression

Aug. 17, 2021

Jasan Bio Medicine (Jiaxing) synthesizes new DHFR inhibitors

Aug. 17, 2021

Chinese researchers divulge new PD-1/PD-L1 interaction inhibitors

Aug. 17, 2021

Chengdu Biobel patents compounds for C. difficile infection

Aug. 17, 2021

Moderna initiates phase I/II study of mRNA-3705 for methylmalonic acidemia

Aug. 17, 2021

Phase II study initiated to assess aspacytarabine in AML and MDS patients

Aug. 17, 2021

Aberrant NAD+ metabolism underlies Zika microcephaly

Aug. 17, 2021

FDA lifts clinical hold on trial of Danon disease treatment RP-A501

Aug. 16, 2021

LAVA Therapeutics cleared to initiate clinical trial of LAVA-1207

Aug. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...